America has much greatness left in her.
Senator Rand Paul
Verified account Senate Republicans@SenRandPaul
I fight for Kentucky, individual rights, and the Constitution | This is an official government account for Senator Rand Paul.
466 Following 363K Followers 6K Posts
Latest posts 5
I awarded Copperhead Gun and Range in Prestonsburg Small Business of the Week!
Read more here: floydct.com/news/copperhea…
Read more here: floydct.com/news/copperhea…
0:55
Preserving the Electoral College protects liberty from one party installing a president and the tyranny that follows.
Opposition to this is simply fervor for easy, fast power grabs that silence the rest of the country.
Opposition to this is simply fervor for easy, fast power grabs that silence the rest of the country.
The electoral college is, without question, an inseparable friend to those who believe that every American across our vast country deserves to be heard.
We must fight to defend it from the far Left.
We must fight to defend it from the far Left.
.@NTU names my bill S.1414 a 'no-brainer.'
My bill would eliminate default blanket requirements from the government that keep prescription drug costs high, delay development, and undermine competition in the biologic and biosimilar markets.
This is common sense!
My bill would eliminate default blanket requirements from the government that keep prescription drug costs high, delay development, and undermine competition in the biologic and biosimilar markets.
This is common sense!
Biosimilar Red Tape Elimination Act
Bill Number: S. 1414
Lead Sponsors: @SenRandPaul, @SenMikeLee, and @SenatorHassan
It’s a No Brainer: This streamlines the Food and Drug Administration’s (FDA) convoluted and obsolete approval process for biosimilar drugs. Under current law, manufacturers are required to undertake costly and lengthy clinical studies even when the evidence already shows that the biosimilar they have developed is as safe and effective as the original product. There is ample evidence that prices decline as more competitors enter the market for a given drug. Public policy should, therefore, focus on removing regulatory barriers to entry that keep manufacturers from bringing their drugs to market. Deploying innovative drugs can help lower costs in taxpayer-funded health care programs by obviating the need for more expensive procedures or hospitalizations.View quoted post on X
